National Health Investors Enters Material Definitive Agreement
Ticker: NHI · Form: 8-K · Filed: Aug 16, 2024 · CIK: 877860
Sentiment: neutral
Topics: material-agreement, financials
TL;DR
NHI signed a big deal, filing shows. Details TBD.
AI Summary
On August 14, 2024, National Health Investors Inc. entered into a material definitive agreement. The company also filed financial statements and exhibits as part of this report. Specific details of the agreement and financial information were not disclosed in the provided text.
Why It Matters
This filing indicates a significant new contract or transaction for National Health Investors Inc., which could impact its future financial performance and strategic direction.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which suggests a significant event, but the lack of specific details about the agreement introduces uncertainty.
Key Players & Entities
- NATIONAL HEALTH INVESTORS INC (company) — Registrant
- August 14, 2024 (date) — Date of Earliest Reported
- 222 Robert Rose Drive, Murfreesboro, TN 37129 (address) — Principal executive offices
- 615-890-9100 (phone_number) — Registrant's telephone number
FAQ
What type of material definitive agreement did National Health Investors Inc. enter into?
The filing states that National Health Investors Inc. entered into a material definitive agreement on August 14, 2024, but does not specify the nature or terms of the agreement.
When was the earliest reported date for this filing?
The earliest reported date for this filing is August 14, 2024.
What is the principal executive office address for National Health Investors Inc.?
The principal executive office address is 222 Robert Rose Drive, Murfreesboro, TN 37129.
What is the IRS Employer Identification Number for National Health Investors Inc.?
The IRS Employer Identification Number for National Health Investors Inc. is 62-1470956.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the 'Entry into a Material Definitive Agreement' and 'Financial Statements and Exhibits'.
Filing Stats: 1,432 words · 6 min read · ~5 pages · Grade level 11.1 · Accepted 2024-08-16 16:02:59
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value NHI New York Stock Exchan
- $68.40 — of Common Stock to the Underwriters of $68.40 (the "Offering"). The Offering was made
- $188.3 m — ted offering expenses, of approximately $188.3 million, subject to the price adjustment
Filing Documents
- d866815d8k.htm (8-K) — 33KB
- d866815dex11.htm (EX-1.1) — 223KB
- d866815dex12.htm (EX-1.2) — 169KB
- d866815dex13.htm (EX-1.3) — 169KB
- d866815dex14.htm (EX-1.4) — 170KB
- d866815dex15.htm (EX-1.5) — 166KB
- d866815dex51.htm (EX-5.1) — 10KB
- g866815g0816064507094.jpg (GRAPHIC) — 2KB
- 0001193125-24-202116.txt ( ) — 1277KB
- nhi-20240814.xsd (EX-101.SCH) — 2KB
- nhi-20240814_lab.xml (EX-101.LAB) — 17KB
- nhi-20240814_pre.xml (EX-101.PRE) — 11KB
- d866815d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1* Underwriting Agreement, dated as of August 14, 2024, by and among the Company and BofA Securities, Inc., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and BMO Capital Markets Corp., as representatives of the several underwriters listed on Schedule A thereto, the Forward Sellers and the Forward Purchasers. 1.2 Forward Sale Agreement, dated August 14, 2024, by and between the Company and BofA Securities, Inc. (or its affiliate). 1.3 Forward Sale Agreement, dated August 14, 2024, by and between the Company and J.P. Morgan Securities LLC (or its affiliate). 1.4 Forward Sale Agreement, dated August 14, 2024, by and between the Company and Wells Fargo Securities, LLC (or its affiliate). 1.5 Forward Sale Agreement, dated August 14, 2024, by and between the Company and BMO Capital Markets Corp. (or its affiliate). 5.1 Opinion of Hogan Lovells US LLP with respect to the legality of the shares of Common Stock. 23.1 Consent of Hogan Lovells US LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Pursuant to Item 601(a)(5) of Regulation S-K, certain schedules and exhibits have been omitted.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NATIONAL HEALTH INVESTORS, INC. Date: August 16, 2024 By: /s/ John L. Spaid Name: John L. Spaid Title: Chief Financial Officer